OTCPK:ARLZQ - Post by User
Comment by
GoldenDilemmaon Nov 16, 2016 9:50am
108 Views
Post# 25467725
RE:Adams shouldn't sell ARLZ for less than $25/Share.
RE:Adams shouldn't sell ARLZ for less than $25/Share. Yosprala not even approved in Canada or EU. Global sales non existent.
Don't put the cart before the horse. There will not be a BO until the business model is flushed out. Years down the road.